Table 3 |
|||||||||
|
Test characteristics of fecal calprotectin to predict a clinically significant gastrointestinal finding |
|||||||||
|
Clinically significant finding |
AUC (95%CI) |
Cut-off (μg/g) |
Sens (%) |
Spec (%) |
LR+ |
LR- |
NPV (%) |
PPV (%) |
Accuracy (%) |
|
|
|||||||||
|
Overall |
0.877 (0.85 - 0.90) |
50 |
73 |
93 |
10.8 |
0.29 |
88 |
84 |
85 |
|
Upper gastrointestinal tract |
0.730 (0.66 - 0.79) |
48 |
59 |
82 |
3.2 |
0.50 |
75 |
68 |
71 |
|
Lower gastrointestinal tract |
0.912 (0.88 - 0.94) |
50 |
84 |
92 |
10.6 |
0.17 |
82 |
93 |
89 |
|
|
|||||||||
|
Area under the receiver operating characteristics curve (AUC) with corresponding sensitivity (Sens), specificity (Spec), positive and negative likelihood ratio (LR+, LR-), and negative and positive predictive values (NPV, PPV) for fecal calprotectin to identify a clinically significant finding in the gastrointestinal tract. Overall accuracy was calculated using the following formula: (true positive test results + true negative test results)/total population. |
|||||||||
|
Manz et al. BMC Gastroenterology 2012 12:5 doi:10.1186/1471-230X-12-5 |
|||||||||